Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis
about
Novel treatment options for portal hypertension.Significance of angiotensin 1-7 coupling with MAS1 receptor and other GPCRs to the renin-angiotensin system: IUPHAR Review 22.Novelties in the pathophysiology and management of portal hypertension: new treatments on the horizon.Anti-atherosclerotic effect of the angiotensin 1-7 mimetic AVE0991 is mediated by inhibition of perivascular and plaque inflammation in early atherosclerosis.Mouse and Rat Models of Induction of Hepatic Fibrosis and Assessment of Portal Hypertension.Managing portal hypertension in patients with liver cirrhosis.
P2860
Hemodynamic Effects of the Non-Peptidic Angiotensin-(1-7) Agonist AVE0991 in Liver Cirrhosis
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Hemodynamic Effects of the Non ...... ist AVE0991 in Liver Cirrhosis
@ast
Hemodynamic Effects of the Non ...... ist AVE0991 in Liver Cirrhosis
@en
type
label
Hemodynamic Effects of the Non ...... ist AVE0991 in Liver Cirrhosis
@ast
Hemodynamic Effects of the Non ...... ist AVE0991 in Liver Cirrhosis
@en
prefLabel
Hemodynamic Effects of the Non ...... ist AVE0991 in Liver Cirrhosis
@ast
Hemodynamic Effects of the Non ...... ist AVE0991 in Liver Cirrhosis
@en
P2093
P2860
P50
P1433
P1476
Hemodynamic Effects of the Non ...... ist AVE0991 in Liver Cirrhosis
@en
P2093
Chandana B Herath
Christian P Strassburg
Josephine Grace
Peter W Angus
Sabine Klein
Thomas Walther
Tilman Sauerbruch
Tom Haltenhof
P2860
P304
P356
10.1371/JOURNAL.PONE.0138732
P407
P577
2015-09-25T00:00:00Z